November 2018 News Round Up


The end of INF: Another nuclear treaty bites the dust On October 20, US President Donald Trump announced that he intends to withdraw the United States from the 1987 Intermediate-Range Nuclear Forces Treaty (INF) with Moscow.
How chemical weapons have helped bring Assad close to victory After seven devastating years of civil war in Syria, which have left more than 350,000 people dead, President Bashar al-Assad appears close to victory against the forces trying to overthrow him.
Vanuatu awards international drone companies with commercial contracts for vaccine delivery In a global first, the Vanuatu Government has awarded two international drone companies, Swoop Aero and Wingcopter, with commercial contracts to trial the use of drones to bring lifesaving vaccines to children living in remote rural islands.
Saudi crown prince launches project for first nuclear plant in Saudi Arabia Saudi’s crown prince on Monday launched a project to build the first nuclear research reactor in the kingdom, the Saudi Press Agency reported.
DR Congo Ebola outbreak ‘worst’ in country’s history The Democratic Republic of Congo is facing the worst Ebola outbreak in the country’s history, according to officials.
British Army start biggest military robot exercise in British history, Defence Secretary announces British troops will today begin testing out over 70 examples of futuristic technology including enhanced surveillance drones and unmanned vehicles on the fields of Salisbury Plain, Defence Secretary Gavin Williamson has announced.
Kim Jong Un tests ‘high-tech’ weapon in message to the US North Korea has tested a “newly developed ultramodern” weapon in an event supervised by leader Kim Jong Un, state media said Friday, amid faltering nuclear disarmament negotiations with the United States.

Congo health workers face violence as Ebola virus spreads
The death toll from the Ebola outbreak in the Democratic Republic of Congo continues to rise as violence hampers health workers’ efforts to battle the virus.


New test rapidly identifies antibiotic-resistant ‘superbugs’
When you get sick, you want the right treatment fast. But certain infectious microbes are experts at evading the very anti-bacterial drugs designed to fight them.
Uncovering secret structure to safer explosives A team of scientists at Lawrence Livermore National Laboratory (LLNL) has shown that the structure of microscopic pores in high explosive materials can significantly impact performance and safety.
Probiotics and antibiotics create a killer combination to eradicate drug-resistant bacteria In a new study, the researchers showed that by delivering a combination of antibiotic drugs and probiotics, they could eradicate two strains of drug-resistant bacteria that often infect wounds.
The composition of gut bacteria almost recovers after antibiotics The use of antibiotics has long been associated with the breakdown of intestinal bacteria. Now a new study from the University of Copenhagen shows that the composition and function of intestinal bacteria can be restored after antibiotic treatment of healthy people.
Sniffer dogs could detect malaria in people
Freya, a Springer Spaniel, is one of the dogs who has been trained to sniff out the scent of malaria. Freya’s highly sensitive nose could help provide the first non-invasive test for the disease.
New ‘Trojan horse’ antibiotic promising A new antibiotic is effective at treating complicated multidrug-resistant urinary tract infections, researchers have claimed.
How antibiotic resistance could take us back to the ‘dark ages’ We face a return to the dark ages of life-threatening surgery unless we can preserve the infection-killing powers of antibiotics, according to England’s chief medical officer.
Llama blood clue to beating all flu s the search for the key ingredient for a universal flu vaccine finally over? Thanks to llama antibodies, researchers were able to produce an antibody therapy that can potentially combat all types of flu.

Throughout the CBRN Europe website there are links to other external websites. Whilst every effort is made to ensure that these website content is suitable, CBRN Europe cannot be held responsible for the content of these external site